Gland Pharma Limited (GLAND.NS) NSE
1,795.40
-5.2(-0.29%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
1,795.40
-5.2(-0.29%)
Currency In INR
| Market Cap | 255.94B |
| Enterprise Value | 233.52B |
| P/E Ratio | 34.92 |
| PEG Ratio | 1.72 |
| Price/Sales Ratio | 4.84 |
| Price/Book Ratio | 3.09 |
| Enterprise/Revenue | 4.45 |
| Enterprise/EBITDA | 17.52 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.14 |
| Operating Margin | 0.16 |
| Return On Assets | 0.07 |
| Return On Equity | 0.09 |
| Revenue | 56.17B |
| Revenue/Share | 371.01 |
| Gross Profit | 31.54B |
| EBITDA | 12.31B |
| Net Income | 6.99B |
| Diluted EPS | 42.4 |
| Total Cash | 27.04B |
| Total Cash/Share | 164.11 |
| Total Debt | 3.02B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 4.13 |
| Book Value Per Share | 580.39 |
| 52-Week Change | 21.42 |
| 52-Week High | 2,131 |
| 52-Week Low | 1,382.3 |
| Moving Average 50 Days | 1,740.01 |
| Moving Average 200 Days | 1,831.33 |
| Average Volume | 154,766 |
| Shares Outstanding | 164.76M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 18 |
| Trailing Annual Dividend Yield | 1 |
| Payout Ratio | 0.35 |
| Last Split Factor | N/A |
| Last Split Date | N/A |